Burleson & Co’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$328K Buy
3,418
+1
+0% +$90 0.08% 107
2022
Q3
$250K Sell
3,417
-18
-0.5% -$1.5K 0.05% 116
2022
Q2
$273K Buy
3,435
+15
+0.4% +$1.32K 0.06% 105
2022
Q1
$335K Buy
3,420
+255
+8% +$24.1K 0.05% 114
2021
Q4
$294K Buy
3,165
+1
+0% +$94 0.04% 123
2021
Q3
$298K Buy
3,164
+1
+0% +$100 0.04% 115
2021
Q2
$304K Sell
3,163
-84
-3% -$7.9K 0.04% 117
2021
Q1
$293K Buy
3,247
+86
+3% +$7.4K 0.05% 111
2020
Q4
$254K Buy
3,161
+1
+0% +$74 0.04% 121
2020
Q3
$222K Hold
3,160
0.04% 128
2020
Q2
$210K Buy
+3,160
New +$179K 0.05% 119
2020
Q1
Sell
-3,160
Closed -$243K 122
2019
Q4
$243K Hold
3,160
0.07% 111
2019
Q3
$223K Buy
+3,160
New +$199K 0.08% 98
2019
Q2
Sell
-3,160
Closed -$225K 104
2019
Q1
$225K Hold
3,160
0.1% 102
2018
Q4
$214K Hold
3,160
0.11% 94
2018
Q3
$216K Sell
3,160
-151
-5% -$11.1K 0.12% 97
2018
Q2
$229K Buy
+3,311
New +$233K 0.13% 101

Other funds holding EMR

Burleson & Co's EMR Position: Q4 2022 in Review

Burleson & Co increased its Emerson Electric (EMR) stake by 0.03% in Q4 2022, buying an estimated $90 and bringing the position to 3,418 shares worth $328K. The position accounts for 0.08% of the portfolio, ranked #107.

Burleson & Co first reported a position in EMR in Q2 2018 and has held it in 17 quarters since. The position peaked at $335K in Q1 2022. 1,795 funds tracked by Wall St. Rank hold EMR as of Q4 2022.

  • Burleson & Co held 3,418 shares of Emerson Electric worth $328K as of Q4 2022.
  • Burleson & Co bought 1 Emerson Electric share in Q4 2022, an estimated $90.
  • Emerson Electric made up 0.08% of Burleson & Co's portfolio in Q4 2022, its #107 holding.
  • Burleson & Co first reported a position in Emerson Electric in Q2 2018 and has held it in 17 quarters since.
  • Burleson & Co's Emerson Electric position peaked at $335K in Q1 2022.
  • 1,795 funds tracked by Wall St. Rank held Emerson Electric as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.